<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Microbes in the Moonlight: How the Gut Microbiota Influences Sleep - Health AI Hub</title>
    <meta name="description" content="This paper reviews the critical role of the gut microbiota in regulating sleep physiology via the gut-microbiota-brain axis (GMBA), detailing how microbial comp">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Microbes in the Moonlight: How the Gut Microbiota Influences Sleep</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.02766v2" target="_blank">2511.02766v2</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-04
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Enso Onill Torres Alegre
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.NC
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.02766v2" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.02766v2" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper reviews the critical role of the gut microbiota in regulating sleep physiology via the gut-microbiota-brain axis (GMBA), detailing how microbial composition influences neural, endocrine, and immune pathways, as well as neurotransmitter production, circadian rhythms, and metabolic homeostasis. It highlights that gut dysbiosis contributes to sleep disorders and associated pathologies by altering key metabolic pathways, proposing microbiota-targeted therapies as promising interventions.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>The findings underscore the gut microbiota as a crucial, modifiable factor in sleep health, offering novel therapeutic avenues for widespread sleep disorders, neurodegenerative conditions, metabolic syndromes, and mood disorders by targeting gut health and its intricate communication with the brain and other systems.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The abstract does not mention any application of AI in health or medicine. While AI could potentially be used to analyze complex microbiota data or predict individual responses to microbiota-targeted therapies, it is not discussed within the scope of this paper's abstract.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>The gut microbiota acts as a fundamental regulator of sleep physiology through the gut-microbiota-brain axis (GMBA), influencing neural, endocrine, and immune pathways.</li>
                    
                    <li>The GMBA modulates critical physiological processes including neurotransmitter (e.g., serotonin, GABA) production, circadian rhythms, and metabolic homeostasis.</li>
                    
                    <li>Disruptions in gut microbial composition (dysbiosis) are directly linked to the pathogenesis of sleep disorders, neuroinflammation, and systemic immune dysfunction.</li>
                    
                    <li>Gut dysbiosis contributes to sleep disturbances by altering the metabolism of key compounds like serotonin, GABA, and short-chain fatty acids (SCFAs).</li>
                    
                    <li>These microbiota-mediated disruptions in sleep have significant implications for a range of severe health conditions, including neurodegenerative diseases, metabolic syndromes, and mood disorders.</li>
                    
                    <li>Emerging microbiota-targeted therapies such as probiotics, fecal microbiota transplantation (FMT), and chrononutrition are proposed as potential interventions to restore sleep homeostasis and improve health outcomes.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>This paper is a comprehensive review, integrating existing and emerging research on the intricate connections between sleep and the gut microbiota, and exploring potential therapeutic interventions based on current scientific understanding.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The gut microbiota fundamentally regulates sleep physiology by influencing neural, endocrine, and immune pathways through the GMBA, modulating neurotransmitter (serotonin, GABA) production, circadian rhythms, and metabolic homeostasis. Gut dysbiosis directly contributes to sleep disturbances, neuroinflammation, and systemic immune dysfunction by altering key metabolic pathways, including those for short-chain fatty acids (SCFAs), with profound implications for neurodegenerative, metabolic, and mood disorders.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The identification of specific microbiota-mediated mechanisms underlying sleep disturbances offers novel targets for intervention. Probiotics, fecal microbiota transplantation (FMT), and chrononutrition are highlighted as promising microbiota-targeted therapies that could restore sleep homeostasis, alleviate sleep disorders, and potentially mitigate associated conditions like neurodegenerative diseases, metabolic syndromes, and mood disorders, thus offering new strategies for patient care.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract for this review paper does not explicitly state any limitations of the research or current understanding, such as the stage of clinical evidence for the proposed therapies or the complexity of the GMBA mechanisms.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The paper implicitly suggests future research should focus on further exploring and validating microbiota-targeted therapies such as probiotics, fecal microbiota transplantation (FMT), and chrononutrition as effective clinical interventions to restore sleep homeostasis and improve overall health outcomes, requiring more rigorous preclinical and human studies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Gastroenterology</span>
                    
                    <span class="tag">Endocrinology</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Psychiatry</span>
                    
                    <span class="tag">Sleep Medicine</span>
                    
                    <span class="tag">Metabolic Disorders</span>
                    
                    <span class="tag">Neurogastroenterology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">gut microbiota</span>
                    
                    <span class="tag tag-keyword">sleep</span>
                    
                    <span class="tag tag-keyword">gut-microbiota-brain axis (GMBA)</span>
                    
                    <span class="tag tag-keyword">dysbiosis</span>
                    
                    <span class="tag tag-keyword">neurotransmitters</span>
                    
                    <span class="tag tag-keyword">probiotics</span>
                    
                    <span class="tag tag-keyword">fecal microbiota transplantation (FMT)</span>
                    
                    <span class="tag tag-keyword">chrononutrition</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The gut microbiota has emerged as a fundamental regulator of sleep
physiology, influencing neural, endocrine, and immune pathways through the
gut-microbiota-brain axis (GMBA). This bidirectional communication system
modulates neurotransmitter production, circadian rhythms, and metabolic
homeostasis, while disruptions in microbial composition have been linked to
sleep disorders, neuroinflammation, and systemic immune dysfunction. Recent
findings suggest that gut dysbiosis contributes to sleep disturbances by
altering serotonin, GABA, and short-chain fatty acid (SCFA) metabolism, with
implications for neurodegenerative diseases, metabolic syndromes, and mood
disorders. Additionally, the gut microbiota interacts with the endocrine and
immune systems, shaping inflammatory responses and stress adaptation
mechanisms. This review explores the intricate connections between sleep and
the gut microbiota, integrating emerging research on microbiota-targeted
therapies, such as probiotics, fecal microbiota transplantation (FMT), and
chrononutrition, as potential interventions to restore sleep homeostasis and
improve health outcomes</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>31 pages, 2 tables, 1 figure. Review article on the gut microbiota
  sleep axis</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>